Spots Global Cancer Trial Database for carcinoma, small cell
Every month we try and update this database with for carcinoma, small cell cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned | NCT00191750 | Carcinoma, Smal... | Pemetrexed | 18 Years - | Eli Lilly and Company | |
| CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | NCT04660929 | HER2-positive Adenocarcinoma Bile Duct Cance... Biliary Tract C... Bladder Cancer Breast Cancer Breast Neoplasm Carcinoma, Duct... Carcinoma, Hepa... Cancer Lung Cancer, No... Carcinoma, Ovar... Carcinoma, Smal... Carcinoma, Squa... Carcinoma, Tran... Colorectal Canc... Esophagogastric... Inflammatory Br... Stomach Neoplas... Malignant Neopl... Ovarian Neoplas... Pancreatic Canc... HER2-positive S... HER2-positive B... HER2-positive G... HER-2 Protein O... HER-2 Gene Ampl... Prostate Cancer Head and Neck C... Endometrial Can... Lung Cancer, Sm... | CT-0508 Pembrolizumab | 18 Years - | Carisma Therapeutics Inc | |
| Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma | NCT00413075 | Solid Tumor Lymphoma | oral belinostat | 18 Years - | Valerio Therapeutics | |
| A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens | NCT03092739 | Carcinoma, Non-... Carcinoma, Smal... | PD-L1 Immunocyt... PD-L1 Immunohis... | - | Hoffmann-La Roche | |
| Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy | NCT00100256 | Lung Neoplasms Carcinoma, Non-... Carcinoma, Smal... Neoplasm Recurr... | Rhenium (Re 188... | 21 Years - | Andarix Pharmaceuticals | |
| Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers | NCT03212404 | Lung Neoplasms Carcinoma, Non-... Carcinoma, Smal... Malignant Mesot... Head and Neck C... Melanoma Merkel Cell Car... Renal Cell Carc... Urothelial Carc... Classical Hodgk... Cutaneous Squam... Non Hodgkin Lym... Endometrial Can... | CK-301 (cosibel... | 18 Years - | Checkpoint Therapeutics, Inc. | |
| A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy | NCT00447421 | Small Cell Lung... Carcinoma, Smal... SCLC | pemetrexed cisplatin radiation | 18 Years - | Eli Lilly and Company | |
| Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer | NCT00298896 | Carcinoma, Smal... Small Cell Lung... | SNS-595 | 18 Years - | Sunesis Pharmaceuticals | |
| Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
| A Phase I Study of iPS Cell Generation From Patients With COPD | NCT01860898 | Thoracic Diseas... Respiratory Tra... Cancer of Lung Cancer of the L... Lung Cancer Lung Diseases, ... COPD Pulmonary Emphy... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Carcinoma, Smal... | Skin Biopsy | 18 Years - | Mayo Clinic | |
| Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient | NCT00826644 | Carcinoma, Smal... | Belotecan Etoposide Cisplatin | 19 Years - 80 Years | Chonnam National University Hospital | |
| Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring | NCT05500391 | Stage I Testicu... Stage I Testicu... Gastrointestina... Ovarian Germ Ce... Adenocarcinoma,... Borderline Ovar... Sex Cord-Stroma... Mucinous Adenoc... Carcinoma, Smal... Carcinosarcoma,... Serous Tumor of... Glioma Neuroendocrine ... Aggressive Fibr... | Oncological Fol... | 18 Years - | Centre Oscar Lambret | |
| A Phase I Study of iPS Cell Generation From Patients With COPD | NCT01860898 | Thoracic Diseas... Respiratory Tra... Cancer of Lung Cancer of the L... Lung Cancer Lung Diseases, ... COPD Pulmonary Emphy... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Carcinoma, Smal... | Skin Biopsy | 18 Years - | Mayo Clinic | |
| A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer | NCT00359359 | Carcinoma, Smal... | Sagopilone (BAY... Cisplatin | 18 Years - | Bayer | |
| Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers | NCT03212404 | Lung Neoplasms Carcinoma, Non-... Carcinoma, Smal... Malignant Mesot... Head and Neck C... Melanoma Merkel Cell Car... Renal Cell Carc... Urothelial Carc... Classical Hodgk... Cutaneous Squam... Non Hodgkin Lym... Endometrial Can... | CK-301 (cosibel... | 18 Years - | Checkpoint Therapeutics, Inc. | |
| Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma | NCT00413075 | Solid Tumor Lymphoma | oral belinostat | 18 Years - | Valerio Therapeutics | |
| A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned | NCT00191750 | Carcinoma, Smal... | Pemetrexed | 18 Years - | Eli Lilly and Company | |
| BI 2536 Second Line Monotherapy in SCLC | NCT00412880 | Carcinoma, Smal... | BI 2536 | 18 Years - | Boehringer Ingelheim | |
| Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer | NCT00305942 | Carcinoma, Smal... | Topotecan carboplatin | 18 Years - | SCRI Development Innovations, LLC | |
| Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient | NCT00826644 | Carcinoma, Smal... | Belotecan Etoposide Cisplatin | 19 Years - 80 Years | Chonnam National University Hospital | |
| Temozolomide as Maintenance Therapy in Small Cell Lung Cancer | NCT01900951 | Carcinoma, Smal... | Temozolomide | 18 Years - 75 Years | Chinese PLA General Hospital | |
| BI 2536 Second Line Monotherapy in SCLC | NCT00412880 | Carcinoma, Smal... | BI 2536 | 18 Years - | Boehringer Ingelheim | |
| Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer | NCT02675088 | Carcinoma, Smal... Lung Neoplasms | high-dose TRT standard-dose T... | 18 Years - 70 Years | ChineseAMS | |
| A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens | NCT03092739 | Carcinoma, Non-... Carcinoma, Smal... | PD-L1 Immunocyt... PD-L1 Immunohis... | - | Hoffmann-La Roche | |
| Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer | NCT00298896 | Carcinoma, Smal... Small Cell Lung... | SNS-595 | 18 Years - | Sunesis Pharmaceuticals | |
| Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients | NCT00906061 | Carcinoma, Non-... | Gemcitabine and... | 18 Years - | Hospital Arnau de Vilanova | |
| Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
| Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
| CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | NCT04660929 | HER2-positive Adenocarcinoma Bile Duct Cance... Biliary Tract C... Bladder Cancer Breast Cancer Breast Neoplasm Carcinoma, Duct... Carcinoma, Hepa... Cancer Lung Cancer, No... Carcinoma, Ovar... Carcinoma, Smal... Carcinoma, Squa... Carcinoma, Tran... Colorectal Canc... Esophagogastric... Inflammatory Br... Stomach Neoplas... Malignant Neopl... Ovarian Neoplas... Pancreatic Canc... HER2-positive S... HER2-positive B... HER2-positive G... HER-2 Protein O... HER-2 Gene Ampl... Prostate Cancer Head and Neck C... Endometrial Can... Lung Cancer, Sm... | CT-0508 Pembrolizumab | 18 Years - | Carisma Therapeutics Inc | |
| Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC | NCT02688036 | Carcinoma, Smal... Lung Neoplasms | hypofractionate... conventionally ... | 18 Years - 70 Years | ChineseAMS | |
| Study of Arsenic Trioxide in Small Cell Lung Cancer | NCT01470248 | Lung Cancer Cancer of Lung Pulmonary Cance... Pulmonary Neopl... Carcinoma, Smal... | Arsenic Trioxid... | 18 Years - | Emory University | |
| Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung Cancer | NCT00129974 | Carcinoma, Smal... | pemetrexed and ... | 18 Years - | Tufts Medical Center | |
| A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide | NCT00537511 | Carcinoma, Smal... | Pomalidomide Cisplatin Etoposide | 18 Years - | Celgene | |
| TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES) | NCT02608411 | Carcinoma, Smal... | ARQ197 | 18 Years - | Istituto Oncologico Veneto IRCCS | |
| Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient | NCT00826644 | Carcinoma, Smal... | Belotecan Etoposide Cisplatin | 19 Years - 80 Years | Chonnam National University Hospital | |
| Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer | NCT00284154 | Carcinoma, Smal... Lung Cancer | Vinflunine | 18 Years - | SCRI Development Innovations, LLC | |
| A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens | NCT03092739 | Carcinoma, Non-... Carcinoma, Smal... | PD-L1 Immunocyt... PD-L1 Immunohis... | - | Hoffmann-La Roche | |
| Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC | NCT02688036 | Carcinoma, Smal... Lung Neoplasms | hypofractionate... conventionally ... | 18 Years - 70 Years | ChineseAMS | |
| Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer | NCT00126828 | Carcinoma, Smal... | External beam r... | 18 Years - | AHS Cancer Control Alberta | |
| Neurocognitive Function After Prophylactic Cranial Irradiation & Hippocampal Sparing in LD SCLC Patients - a Pilot Study | NCT02366741 | Carcinoma, Smal... | Whole brain rad... | 18 Years - | Sheba Medical Center | |
| Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma | NCT02034123 | Carcinoma, Smal... | GSK2879552 | 18 Years - | GlaxoSmithKline | |
| Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum | NCT00094978 | Carcinoma, Smal... Carcinoma, Non-... Esophageal Neop... Mesothelioma | Depsipeptide Flavopiridol (a... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers | NCT03212404 | Lung Neoplasms Carcinoma, Non-... Carcinoma, Smal... Malignant Mesot... Head and Neck C... Melanoma Merkel Cell Car... Renal Cell Carc... Urothelial Carc... Classical Hodgk... Cutaneous Squam... Non Hodgkin Lym... Endometrial Can... | CK-301 (cosibel... | 18 Years - | Checkpoint Therapeutics, Inc. | |
| BI 2536 Second Line Monotherapy in SCLC | NCT00412880 | Carcinoma, Smal... | BI 2536 | 18 Years - | Boehringer Ingelheim | |
| Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer | NCT00294190 | Small Cell Lung... Carcinoma, Smal... | Topotecan | 18 Years - | SCRI Development Innovations, LLC | |
| Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) | NCT05461430 | Pleural Effusio... Ascites, Malign... Carcinoma Carcinoma, Hepa... Carcinoma, Rena... Carcinoma, Rena... Carcinoma, Smal... Carcinoma, Non-... Carcinoma, Panc... Carcinoma, Neur... Carcinoma, Thym... Carcinoma, Panc... Carcinoma Breas... Carcinoma, Ovar... Carcinoma Bladd... Carcinoma of Un... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of Es... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Cholangiocarcin... Melanoma Mesothelioma Pancreatic Canc... | 18 Years - | Travera Inc |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
